Skip to main content
. Author manuscript; available in PMC: 2010 Nov 15.
Published in final edited form as: Int J STD AIDS. 2009 Jan;20(1):46–51. doi: 10.1258/ijsa.2008.008128

Figure 2. Effect of Prevalence of Unidentified HIV on the Incremental Cost-Effectiveness of Once-per-lifetime HIV Screening.

Figure 2

Solid line depicts incremental cost-effectiveness ratio when costs and benefits to sexual partners are included. Dotted line includes costs and benefits to index cases only.